Medication costs as a primary cause of nonadherence in the elderly

Consultant Pharmacist

Volumn 21, Issue 2, 2006, Pages 143-146

  Lynch, Tom ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Case study; Cost; Diabetes mellitus; Medications; Nonadherence

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; DIGOXIN; DIURETIC AGENT; GLIBENCLAMIDE PLUS METFORMIN; GLIPIZIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; METFORMIN; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; VALSARTAN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GENERIC DRUG; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; METOPROLOL; PYRROLE DERIVATIVE;

AGED; ANAMNESIS; ARTHRALGIA; ARTICLE; CASE REPORT; COMMUNITY; DIABETES MELLITUS; DRUG COST; ELDERLY CARE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; LOWEST INCOME GROUP; MEDICARE; NURSING HOME; PHARMACIST; PRESCRIPTION; RETIREMENT; TREATMENT REFUSAL; CORONARY ARTERY DISEASE; COST; DRUG SELF ADMINISTRATION; ECONOMICS; HYPERLIPIDEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE;

AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CORONARY DISEASE; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUGS, GENERIC; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; METFORMIN; METOPROLOL; PATIENT COMPLIANCE; PHARMACISTS; PRESCRIPTIONS, DRUG; PYRROLES; SELF ADMINISTRATION;

EID: 33645519767     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2006.143     Document Type: Article

References (16)

1. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001;16:793-9.
2. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) 2003;22:220-9.
3. Hwang W, Weller W, Ireys H et al. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood) 2001;20:267-78.
4. Tamblyn R, Laprise R, Hanley JA et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
5. Soumerai SB, Ross-Degnan D, Avorn J et al. Effects of Medicaid drug payment limits on admission to hospitals and nursing homes. N Engl J Med 1991;325:1072-7.
6. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 2004;164:1749-55.
7. Kaiser Family Foundation. Estimates of Medicare Beneficiaries' Out-Of-Pocket Drug Spending in 2006. November, 2004. Available at http://www.kff.org.
8. Tseng CW, Brook RH, Keeler E et al. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA 2004;292:952-60.
9. Tangeman H, Patterson JH. Extend-release metoprolol succinate in chronic heart failure. Ann Pharmacother 2003;37:701-10.
10. Shorr RI, Ray WA, Daugherty JR et al. Individual sulfonylureas and serious hypoglycemia in the elderly. J Am Geriatr Soc 1996;44:751-5.
11. Terra SG, Washam JB, Dunham GD, et al. Therapeutic range of digoxin's efficacy in heart failure: what is the evidence? Pharmacotherapy 1999;19:1123-6.
12. Adams KF, Patterson JH, Gattis WA et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 2005;46:497-504.
13. Denus S, Spinier SA, Miller K et al. Statins and liver toxicity: a meta-analysis. Pharmacotherapy 2004;24:584-91.
14. Kaiser Family Foundation. Prescription Drug Trends. October, 2004. Available at http://www.fcff.org.
15. Kaiser Family Foundation. Medicare Chart Book 2005. Summer, 2005. Available at http://www.kff.org.
16. Federman AD. Don't ask, don't tell: the status of doctor-patient communications about health care costs. Arch Intern Med 2004;164:1723-4.